Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
Sex - we can chemically get it up and now last longer?
August 2, 2009
Sciele Pharma And Plethora Solutions Announce Positive Results Of Final Phase III Pivotal Trial For PSD502 For Premature Ejaculation | www.medicalnewstoday.com
?? breakthrough
A missed opportunity - or is it?
June 30, 2009
FDA throws up roadblock for Takeda's diabetes drug | www.fiercebiotech.com
Plusses and minuses of not getting in the market now.
December 16, 2008
Scientists back brain drugs for healthy people | www.washingtonpost.com
This is an abuse of medication - what we don't need
December 15, 2008
FDA: Long-Acting Asthma Drugs Increase Asthma Risks | online.wsj.com
Ruling not unreasonable, but may cause confusion to patients.
August 27, 2008
FDA Alert: Hemorrhagic or Necrotizing Pancreatitis in Patients Taking Byetta | www.fda.gov
If truly an association, this will alter the use of this drug.
Onglyza - ? engagement ring for Astra Zeneca and Bristol-Myers Squibb
July 28, 2008
DDP4 inhibitor class fairly new. Another arrow in the theraputic quiver
July 18, 2008
Drugs to Build Bones May Weaken Them | www.nytimes.com
Patients may ask about this. Haven't heard anyone yet.
Symbicort will give a lift to the little ones
June 6, 2008
AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six | www.pipelinereview.com
Good drug with rapid onset. ? if will create some confusion with adult dosing
Blue Cross Mass. New Payment Plan - A rose by any other name would smell as ?sweet
January 23, 2008
New therapy for old woes, Blue Cross measure aims to slow runaway costs, improve quality of healthcare | www.boston.com
A new idea - I don't think so Trust Blue Cross??????
Lyrica and fibromyalgia - I hope it works
June 25, 2007
Pfizer’s Lyrica Receives FDA Approval for Fibromyalgia | home.businesswire.com
Something actually indicated for this disease.
INTUNIV - another arrow in the quiver is welcome
June 25, 2007
Shire Receives Approvable Letter from FDA for INTUNIV(TM) (guanfacine) Extended Release, a Nonstimulant for the Treatment of ADHD | www.pipelinereview.com
Alternative drug to use. Lower abuse potential Lower stigma
Actonel 75 - the glass 1/2 full?
June 25, 2007
The U.S. Food and Drug Administration Approves New Actonel Dose to Treat and Prevent Postmenopausal Osteoporosis | phx.corporate-ir.net
Compliance issues ? side effects
November 20, 2006
Bayer and Ortho-McNeil, Inc. Outline Phase III Study Program of Oral Factor Xa Inhibitor Rivaroxaban in Chronic Indications | www.pipelinereview.com
An oral anticoagulant that does not require monitoring.
November 20, 2006
Shire Announces Results Of A Meta-Analysis Comparing Stimulant Medications To Non-Stimulant Medications In Treating ADHD In Patients Aged 8 To 15 | www.medicalnewstoday.com
There is a difference between medications. Need to ask what type of patient is being treated.
November 10, 2006
Emisphere Reports Additional Clinical Data From Phase 2 Oral Insulin Trial | www.medicalnewstoday.com
Patients on highest dose - 10 mg 4x/day had best drop. Decreases were 0.1-0.22% depending on the A1C. 2 of 10 had a significant drop to an A1C of 7 or lower.
Page : 11 to 15 of 15
What is potential future for Sequenom in prenatal testing.
November 9, 2009
November 7, 2009
Express Scripts feeling Growing Pains
October 29, 2009
CDC Outlines H1N1 Test Guidelines
October 8, 2009
Why Health Care Costs Keep Rising—And What to Do About It
September 13, 2009